Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2002, v. 17, n. 1, p. 15, doi. 10.1002/hup.368
- By:
- Publication type:
- Article
Works by Henning, Uwe
Results: 13
1
2
Hormone replacement therapy with L-thyroxine promotes working memory and concentration in thyroidectomized female patients after differentiated thyroid carcinoma.
- Published in:
- International Journal of Psychiatry in Medicine, 2020, v. 55, n. 2, p. 114, doi. 10.1177/0091217419885751
- By:
- Publication type:
- Article
3
Homozygosity Mapping of a Gene Locus for Primary Ciliary Dyskinesia on Chromosome 5p and Identification of the Heavy Dynein Chain DNAH5 as a Candidate Gene.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 23, n. 5, p. 696, doi. 10.1165/ajrcmb.23.5.4257
- By:
- Publication type:
- Article
4
Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1125, doi. 10.2147/NDT.S148557
- By:
- Publication type:
- Article
5
Antipsychotic drugs influence transport of the β-adrenergic antagonist [<sup>3</sup>H]-dihydroalprenolol into neuronal and blood cells.
- Published in:
- World Journal of Biological Psychiatry, 2004, v. 5, n. 2, p. 100, doi. 10.1080/15622970410029918
- By:
- Publication type:
- Article
6
Inhibition of p38-mitogen-activated protein kinase may protect from clozapine-induced agranulocytosis.
- Published in:
- World Journal of Biological Psychiatry, 2004, v. 5, n. 1, p. 54, doi. 10.1080/15622970410029909
- By:
- Publication type:
- Article
7
Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis.
- Published in:
- Depression & Anxiety (1091-4269), 2009, v. 26, n. 8, p. E111, doi. 10.1002/da.20405
- By:
- Publication type:
- Article
8
Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity.
- Published in:
- Behavioral & Brain Functions, 2005, v. 1, p. 14, doi. 10.1186/1744-9081-1-14
- By:
- Publication type:
- Article
9
Effect fingerprints of antipsychotic drugs on neural networks in vitro.
- Published in:
- Journal of Neural Transmission, 2019, v. 126, n. 10, p. 1363, doi. 10.1007/s00702-019-02050-8
- By:
- Publication type:
- Article
10
Oxytocin reactivity to an emotional challenge paradigm and its relation to social-cognitive functions in healthy volunteers.
- Published in:
- Journal of Neural Transmission, 2019, v. 126, n. 2, p. 211, doi. 10.1007/s00702-018-1955-4
- By:
- Publication type:
- Article
11
Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.
- Published in:
- Journal of Neural Transmission, 2012, v. 119, n. 5, p. 587, doi. 10.1007/s00702-011-0743-1
- By:
- Publication type:
- Article
12
Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2011, v. 261, n. 8, p. 567, doi. 10.1007/s00406-011-0201-y
- By:
- Publication type:
- Article
13
Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 20, p. 4406, doi. 10.1093/hmg/dds273
- By:
- Publication type:
- Article